Product Introduction:
Afoglip M 20/500 mg Tablet combines Teneligliptin 20 mg, a DPP-4 inhibitor, and Metformin 500 mg, a biguanide. This dual-action formula helps lower blood glucose by increasing insulin release and decreasing glucose production in the liver.
Uses:
-
Management of type 2 diabetes mellitus
-
Used when blood sugar levels are not adequately controlled by Metformin alone
Benefits:
-
Enhances insulin secretion in a glucose-dependent manner
-
Reduces glucose absorption from the intestine
-
Improves insulin sensitivity
-
Lower risk of hypoglycemia compared to sulfonylureas
Composition:
-
Teneligliptin 20 mg
-
Metformin 500 mg
Side Effects:
-
Nausea
-
Diarrhea
-
Headache
-
Abdominal pain
-
Rarely, lactic acidosis (Metformin-related)
Safety Advice:
-
Take after meals to reduce gastrointestinal side effects
-
Regular monitoring of blood sugar and kidney function is advised
-
Avoid alcohol while taking Metformin
-
Use with caution in patients with kidney, liver, or heart conditions
-
Not recommended during pregnancy or breastfeeding unless prescribed
